Multimodality Evaluation of Left Ventricular Remodeling In Mitral Regurgitation: A Pilot Study
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT06770062
- Status
- Recruiting
Conditions
- Left Ventricular Systolic Dysfunction
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Cardiac MRI — DIAGNOSTIC_TESTEach subject will receive two cardiac MRI scans (with and without contrast), one preoperative and another 6-12 months after. The duration of each MRI is approximately 45-60 minutes
Study Details
The purpose of this research is to determine the feasibility of a larger, future study proposing a multimodal approach using cardiac CT and MRI to assess the risk of developing left ventricular (LV) systolic dysfunction in patients with mitral regurgitation (MR).
Key Dates
- Start date
- Jan 20, 2025
- Status verified
- Feb 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 30 participants (estimated)
Arms
- Arm: Chronic severe primary mitral regurgitationAdults with chronic severe primary mitral regurgitation undergoing robotic mitral annuloplasty at Mayo Clinic Rochester
Primary Outcome Measure
Recruitment Rate [ Time Frame: 2 years ]
Central Contacts
- Cardiovascular Surgical Research(507) 266-7982
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic | Rochester | Minnesota | 55905 |
Find similar trials in Rochester, MN
By research site
Related Studies
- Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)PHASE2/PHASE3 · Recruiting · Merck Sharp & Dohme LLC · Los Angeles, California
- A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic DysfunctionPHASE3 · Recruiting · Bayer · Aurora, Colorado
- A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic DysfunctionPHASE3 · Recruiting · Bayer · Aurora, Colorado